The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling
Keywords: Nortrachelogenin; Lignans; TRAIL; Prostate cancer; Receptor tyrosine kinase; Dibenzylbutyrolactone;